SCHEMBL4665583

SCHEMBL4665583

C[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1C#N

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 18/20 0.69
LMNA P02545 2/20 0.57
TP53 P04637 1/20 0.57
TACR2 P21452 5/20 0.56
TSHR P16473 2/20 0.55
KDM4E B2RXH2 2/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
ALDH1A1 P00352 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
NFKB1 P19838 1/20 0.55
MTOR P42345 1/20 0.55
BLM P54132 1/20 0.55
PMP22 Q01453 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
HSD17B10 Q99714 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4477689 0.82 TACR3 (1.00) TACR3LMNATP53TACR2TSHR
SCHEMBL4464383 0.82 TACR3 (1.00) TACR3LMNATP53TACR2TSHR
SCHEMBL4477684 0.82 TACR3 (1.00) TACR3LMNATP53TACR2TSHR
SCHEMBL4668719 0.78 TACR3 (0.57) TACR3TACR2
SCHEMBL4665574 0.78 TACR3 (0.57) TACR3TP53TACR2TSHRMEN1
SCHEMBL4667323 0.78 TACR3 (0.57) TACR3TACR2CYP1A2CYP3A4CYP2D6
SCHEMBL14094494 0.78 TACR3 (0.86) TACR3LMNATP53TACR2TSHR
SCHEMBL14094516 0.77 TACR3 (0.75) TACR3LMNATP53TACR2TSHR
SCHEMBL13971436 0.77 TACR3 (0.69) TACR3LMNATP53TACR2TSHR
SCHEMBL14015159 0.76 TACR3 (0.83) TACR3LMNATP53TACR2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928834-A1 ALKYLNITRILE QUINOLINES, AS NK-3 RECEPTOR LIGANDS AstraZeneca AB (SE) 2008-06-11 EP claimed
WO-2007035157-A1 ALKYLNITRILE QUINOLINES, AS NK-3 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2007-03-29 WO claimed
EP-1928834-A1 ALKYLNITRILE QUINOLINES, AS NK-3 RECEPTOR LIGANDS AstraZeneca AB (SE) 2008-06-11 EP disclosed
WO-2007035157-A1 ALKYLNITRILE QUINOLINES, AS NK-3 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2007-03-29 WO disclosed